GalNAc and lipid nanoparticles enable distinct liver-targeting strategies for metabolic therapy in diabetes

2026 Dataset

View at publisher

Authors: Celia Pilar Martinez‐Jimenez, L Zhang, Gretchen Wolf

DOI: 10.6019/s-bsst2703

Cited by: 0

Fields of Study & Subjects

RNA Interference and Gene Delivery Nanoparticle-Based Drug Delivery Liver Disease Diagnosis and Treatment